Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

[The clinical relevance of drug interactions in patients with human immunodeficiency virus infection: update 2015-2017].

Osorio T L, Rivera C M, Pino-Marín DE, Giraldo NA, Amariles P.

Rev Chilena Infectol. 2019 Aug;36(4):475-489. doi: 10.4067/S0716-10182019000400475. Spanish.

2.

Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.

Roumenina LT, Daugan MV, Noé R, Petitprez F, Vano YA, Sanchez-Salas R, Becht E, Meilleroux J, Clec'h BL, Giraldo NA, Merle NS, Sun CM, Verkarre V, Validire P, Selves J, Lacroix L, Delfour O, Vandenberghe I, Thuilliez C, Keddani S, Sakhi IB, Barret E, Ferré P, Corvaïa N, Passioukov A, Chetaille E, Botto M, de Reynies A, Oudard SM, Mejean A, Cathelineau X, Sautès-Fridman C, Fridman WH.

Cancer Immunol Res. 2019 Jul;7(7):1091-1105. doi: 10.1158/2326-6066.CIR-18-0891. Epub 2019 Jun 4.

3.

Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.

Giraldo NA, Peske JD, Sautès-Fridman C, Fridman WH.

Virchows Arch. 2019 Apr;474(4):463-474. doi: 10.1007/s00428-018-02517-1. Epub 2019 Jan 10. Review.

PMID:
30631935
4.

The clinical role of the TME in solid cancer.

Giraldo NA, Sanchez-Salas R, Peske JD, Vano Y, Becht E, Petitprez F, Validire P, Ingels A, Cathelineau X, Fridman WH, Sautès-Fridman C.

Br J Cancer. 2019 Jan;120(1):45-53. doi: 10.1038/s41416-018-0327-z. Epub 2018 Nov 9. Review.

5.

Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Weinstein AM, Giraldo NA, Petitprez F, Julie C, Lacroix L, Peschaud F, Emile JF, Marisa L, Fridman WH, Storkus WJ, Sautès-Fridman C.

Cancer Immunol Immunother. 2019 Jan;68(1):109-120. doi: 10.1007/s00262-018-2259-0. Epub 2018 Oct 12.

PMID:
30315348
6.

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab.

Giraldo NA, Nguyen P, Engle EL, Kaunitz GJ, Cottrell TR, Berry S, Green B, Soni A, Cuda JD, Stein JE, Sunshine JC, Succaria F, Xu H, Ogurtsova A, Danilova L, Church CD, Miller NJ, Fling S, Lundgren L, Ramchurren N, Yearley JH, Lipson EJ, Cheever M, Anders RA, Nghiem PT, Topalian SL, Taube JM.

J Immunother Cancer. 2018 Oct 1;6(1):99. doi: 10.1186/s40425-018-0404-0.

7.

Immune-based identification of cancer patients at high risk of progression.

Vano YA, Petitprez F, Giraldo NA, Fridman WH, Sautès-Fridman C.

Curr Opin Immunol. 2018 Apr;51:97-102. doi: 10.1016/j.coi.2018.03.005. Epub 2018 Mar 16. Review.

PMID:
29554496
8.

Implications of the tumor immune microenvironment for staging and therapeutics.

Taube JM, Galon J, Sholl LM, Rodig SJ, Cottrell TR, Giraldo NA, Baras AS, Patel SS, Anders RA, Rimm DL, Cimino-Mathews A.

Mod Pathol. 2018 Feb;31(2):214-234. doi: 10.1038/modpathol.2017.156. Epub 2017 Dec 1. Review.

9.

T cells responding to Trypanosoma cruzi detected by membrane TNF-α and CD154 in chagasic patients.

Ripoll JG, Giraldo NA, Bolaños NI, Roa N, Rosas F, Cuéllar A, Puerta CJ, González JM.

Immun Inflamm Dis. 2018 Mar;6(1):47-57. doi: 10.1002/iid3.197. Epub 2017 Oct 1.

10.

Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies.

Petitprez F, Vano YA, Becht E, Giraldo NA, de Reyniès A, Sautès-Fridman C, Fridman WH.

Cancer Immunol Immunother. 2018 Jun;67(6):981-988. doi: 10.1007/s00262-017-2058-z. Epub 2017 Sep 7. Review.

PMID:
28884365
11.

[The clinical relevance of drug interactions in patients with human immunodeficiency virus infection: update 2009-2014].

Giraldo NA, Amariles P, Pino Marín DE, Faus MJ.

Rev Chilena Infectol. 2016 Oct;33(Suppl 1):36-53. doi: 10.4067/S0716-10182016000700005. Review. Spanish.

12.

Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.

Giraldo NA, Becht E, Vano Y, Petitprez F, Lacroix L, Validire P, Sanchez-Salas R, Ingels A, Oudard S, Moatti A, Buttard B, Bourass S, Germain C, Cathelineau X, Fridman WH, Sautès-Fridman C.

Clin Cancer Res. 2017 Aug 1;23(15):4416-4428. doi: 10.1158/1078-0432.CCR-16-2848. Epub 2017 Feb 17.

13.

Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman C, Fridman WH, de Reyniès A.

Genome Biol. 2016 Dec 1;17(1):249. No abstract available.

14.

Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman C, Fridman WH, de Reyniès A.

Genome Biol. 2016 Oct 20;17(1):218. Erratum in: Genome Biol. 2016 Dec 1;17 (1):249.

15.

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention.

Sautès-Fridman C, Lawand M, Giraldo NA, Kaplon H, Germain C, Fridman WH, Dieu-Nosjean MC.

Front Immunol. 2016 Oct 3;7:407. eCollection 2016. Review.

16.

Free software to analyse the clinical relevance of drug interactions with antiretroviral agents (SIMARV®) in patients with HIV/AIDS.

Giraldo NA, Amariles P, Monsalve M, Faus MJ.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):831-839. doi: 10.1016/j.sapharm.2016.09.002. Epub 2016 Sep 23. Review.

PMID:
27751754
17.

Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.

Dieu-Nosjean MC, Giraldo NA, Kaplon H, Germain C, Fridman WH, Sautès-Fridman C.

Immunol Rev. 2016 May;271(1):260-75. doi: 10.1111/imr.12405. Review.

PMID:
27088920
18.

Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.

Becht E, de Reyniès A, Giraldo NA, Pilati C, Buttard B, Lacroix L, Selves J, Sautès-Fridman C, Laurent-Puig P, Fridman WH.

Clin Cancer Res. 2016 Aug 15;22(16):4057-66. doi: 10.1158/1078-0432.CCR-15-2879. Epub 2016 Mar 18.

19.

Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.

Becht E, Giraldo NA, Germain C, de Reyniès A, Laurent-Puig P, Zucman-Rossi J, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH.

Adv Immunol. 2016;130:95-190. doi: 10.1016/bs.ai.2015.12.002. Epub 2016 Jan 29. Review.

PMID:
26923001
20.

Cancer immune contexture and immunotherapy.

Becht E, Giraldo NA, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH.

Curr Opin Immunol. 2016 Apr;39:7-13. doi: 10.1016/j.coi.2015.11.009. Epub 2015 Dec 17. Review.

PMID:
26708937
21.

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC).

Becht E, Giraldo NA, Beuselinck B, Job S, Marisa L, Vano Y, Oudard S, Zucman-Rossi J, Laurent-Puig P, Sautès-Fridman C, de Reyniès A, Fridman WH.

Oncoimmunology. 2015 Aug 7;4(12):e1049804. eCollection 2015 Dec.

22.

The immune response in cancer: from immunology to pathology to immunotherapy.

Giraldo NA, Becht E, Vano Y, Sautès-Fridman C, Fridman WH.

Virchows Arch. 2015 Aug;467(2):127-35. doi: 10.1007/s00428-015-1787-7. Epub 2015 Jun 16. Review.

PMID:
26077464
23.

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer.

Giraldo NA, Becht E, Pagès F, Skliris G, Verkarre V, Vano Y, Mejean A, Saint-Aubert N, Lacroix L, Natario I, Lupo A, Alifano M, Damotte D, Cazes A, Triebel F, Freeman GJ, Dieu-Nosjean MC, Oudard S, Fridman WH, Sautès-Fridman C.

Clin Cancer Res. 2015 Jul 1;21(13):3031-40. doi: 10.1158/1078-0432.CCR-14-2926. Epub 2015 Feb 16.

24.

Tertiary lymphoid structures in cancer and beyond.

Dieu-Nosjean MC, Goc J, Giraldo NA, Sautès-Fridman C, Fridman WH.

Trends Immunol. 2014 Nov;35(11):571-80. doi: 10.1016/j.it.2014.09.006. Epub 2014 Oct 22. Review.

PMID:
25443495
25.

Shaping of an effective immune microenvironment to and by cancer cells.

Becht E, Goc J, Germain C, Giraldo NA, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH.

Cancer Immunol Immunother. 2014 Oct;63(10):991-7. doi: 10.1007/s00262-014-1590-3. Epub 2014 Aug 12. Review.

PMID:
25112529
26.

The immune microenvironment: a major player in human cancers.

Fridman WH, Remark R, Goc J, Giraldo NA, Becht E, Hammond SA, Damotte D, Dieu-Nosjean MC, Sautès-Fridman C.

Int Arch Allergy Immunol. 2014;164(1):13-26. doi: 10.1159/000362332. Epub 2014 May 13. Review.

PMID:
24852691
27.

The immune contexture of primary and metastatic human tumours.

Giraldo NA, Becht E, Remark R, Damotte D, Sautès-Fridman C, Fridman WH.

Curr Opin Immunol. 2014 Apr;27:8-15. doi: 10.1016/j.coi.2014.01.001. Epub 2014 Feb 1. Review.

PMID:
24487185
28.

T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.

Giraldo NA, Bolaños NI, Cuellar A, Roa N, Cucunubá Z, Rosas F, Velasco V, Puerta CJ, González JM.

PLoS Negl Trop Dis. 2013;7(1):e2038. doi: 10.1371/journal.pntd.0002038. Epub 2013 Jan 31.

29.

Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305).

Montoya CJ, Higuita EA, Estrada S, Gutierrez FJ, Amariles P, Giraldo NA, Jimenez MM, Velasquez CP, Leon AL, Rugeles MT, Jaimes FA.

J Infect. 2012 Dec;65(6):549-58. doi: 10.1016/j.jinf.2012.10.016. Epub 2012 Oct 17.

PMID:
23085245
30.

Incidence of nutritional support complications in patient hospitalized in wards. multicentric study.

Agudelo GM, Giraldo NA, Aguilar NL, Restrepo BE, Vanegas M, Alzate S, Martínez M, Gamboa SP, Castaño E, Barbosa J, Román J, Serna AM, Hoyos GM.

Colomb Med (Cali). 2012 Jun 30;43(2):147-53. eCollection 2012 Apr.

31.

[Incidence of nutritional support complications in critical patients: multicenter study].

Agudelo GM, Giraldo NA, Aguilar N, Barbosa J, Castaño E, Gamboa S, Martínez MI, Alzate S, Vanegas M, Restrepo B, Román J, Serna A, Hoyos M.

Nutr Hosp. 2011 May-Jun;26(3):537-45. doi: 10.1590/S0212-16112011000300016. Spanish.

PMID:
21892572
32.

Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients.

Giraldo NA, Bolaños NI, Cuellar A, Guzman F, Uribe AM, Bedoya A, Olaya N, Cucunubá ZM, Roa N, Rosas F, Velasco V, Puerta CJ, González JM.

PLoS Negl Trop Dis. 2011 Aug;5(8):e1294. doi: 10.1371/journal.pntd.0001294. Epub 2011 Aug 23.

33.

[Approach to establishing and evaluating clinical relevance of drug interactions in HIV patients: 2009 update].

Giraldo NA, Amariles P, Gutiérrez FJ, Monsalve M, Faus MJ.

Farm Hosp. 2010 Mar-Apr;34(2):90-3. doi: 10.1016/j.farma.2009.08.004. Epub 2010 Mar 4. Review. Spanish.

PMID:
20206566
34.

[Approach to evaluating the clinical relevance of drug interactions in HIV-infected patients].

Amariles P, Giraldo NA, Faus MJ.

Farm Hosp. 2007 Sep-Oct;31(5):283-302. Review. Spanish.

35.

[Clinical relevance of drug interactions].

Amariles P, Giraldo NA, Faus MJ.

Med Clin (Barc). 2007 Jun 2;129(1):27-35. Review. Spanish.

PMID:
17570184
36.

Prevalence of self-treatment with complementary products and therapies for weight loss: A randomized, cross-sectional Study in Overweight and Obese Patients in Colombia.

Amariles P, González LI, Giraldo NA.

Curr Ther Res Clin Exp. 2006 Jan;67(1):66-78. doi: 10.1016/j.curtheres.2006.02.001.

Supplemental Content

Loading ...
Support Center